Positron-emitting radioligands for studies in vivo-probes for human psychopharmacology
- 1 March 1993
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 7 (2) , 139-158
- https://doi.org/10.1177/026988119300700202
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Functional Mapping of the Human Visual Cortex by Magnetic Resonance ImagingScience, 1991
- Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327European Journal of Clinical Pharmacology, 1991
- 3-(2'-[18F]Fluoroethyl)Spiperone: In vivo Biochemical and Kinetic Characterization in Rodents, Nonhuman Primates, and HumansJournal of Cerebral Blood Flow & Metabolism, 1989
- In vivo [3H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor InternalizationJournal of Cerebral Blood Flow & Metabolism, 1988
- [18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivoEuropean Journal of Pharmacology, 1988
- In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomographyActa Neurologica Scandinavica, 1987
- Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]DeprenylJournal of Neurochemistry, 1987
- Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivativesInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Chirality in bioactive agents and its pitfallsTrends in Pharmacological Sciences, 1986
- []-N-: The radioligand of choice for pett studies of the dopamine receptor in human brainLife Sciences, 1985